Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
04/2008
04/16/2008CN100381428C Quinazolone and quinazolone compound and application thereof
04/16/2008CN100381427C Benzylamine compound, and its preparing method and use
04/16/2008CN100381424C Biaryl sulfonamides and methods for using same
04/15/2008US7358359 Antibacterial agents
04/15/2008US7358262 Using transgenic tumor cells as models for antitumor agent efficacy; tissue targeted therapy and antiproliferative agents
04/15/2008US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
04/15/2008US7358256 Antiproliferative agents; tyrosine kinase inhibitors; anticancer; diseases associated with signal transduction pathways operating through growth factor receptors; 4-amino-1-((4-(3-methoxyphenylamino) quinazolin-5-yl)methyl)-N-methylpiperidine-3-carboxamide
04/15/2008US7358248 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatases
04/15/2008US7358239 Treating impaired fundic relaxation; [1(R),[A-(3 alpha ,4 alpha )]]-1-[1-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-3-methoxy-4-piperidinyl]-2(1H)-pyrimidinone
04/15/2008CA2349325C Process for converting an alcohol to the corresponding fluoride
04/15/2008CA2211981C Production of enantiomerically enriched ortho-substituted .alpha.,.alpha.-diaromatic methanols
04/10/2008WO2008040652A1 Process for synthesis of phenoxy diaminopyrimidine derivatives
04/10/2008WO2008003702A3 Fused bicyclic compounds interacting with the histamine h4 receptor
04/10/2008WO2007110868A3 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
04/10/2008WO2007065662A3 Trisubstituted quinazolinone derivatives as vanilloid antagonists
04/10/2008US20080086004 To a cooled solution of ammonia was added the cooled sulfolane solution of 5-(2,4-diamino-pyrimidin-5-yloxy)-4-isopropyl-2-methoxy-benzenesulfonyl chloride to form -(2,4-diamino-pyrimidin-5-yloxy)-4-isopropyl-2-methoxy-benzenesulfonamide sulfolane solvate
04/10/2008US20080085910 For inflammatory bowel disease; oral administration, bioavailability, pharmacokinetics; 2-(2,6-Dichlorobenzamido)-5-[4-(ethyl-pyrimidin-2-ylamino)phenyl]pent-4-enoic acid methyl ester for example
04/10/2008US20080085907 Reverse transcriptase inhibitors; use against HIV with drug resistance to NNRTI's (Non Nucleoside Reverse Transcriptase Inhibitor drugs); Diaryl Pyrrolo(2,3-d)pyrimidines, diaryl purines, diaryl v-triazolo(4,5-d)pyrimidines
04/10/2008US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof
04/10/2008US20080085890 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof
04/10/2008CA2664305A1 Process for synthesis of phenoxy diaminopyrimidine derivatives
04/09/2008EP1907368A1 2-cyano-pyrimidines and -triazines as cysteine protease inhibitors
04/09/2008EP1907367A1 Design and synthesis of novel tubulin polymerization inhibitors: bonzoylphenyluria (bpu) sulfur analogs
04/09/2008EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials
04/09/2008EP0964864B1 Pyrido 2,3-d pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
04/09/2008EP0958287B2 Sulfamide-metalloprotease inhibitors
04/09/2008CN101157657A Method for preparing azoxystrobin and its analogue
04/09/2008CN100379730C Pyrimidine-sulfamides and their use as endothelian receptor antagonist
04/09/2008CN100379729C Nitro compounds and their application in preparation of pemetrexed
04/08/2008US7355044 Self-assembling dyes
04/08/2008US7354946 Biarylurea derivatives
04/03/2008WO2008039520A2 Fused ring compounds for inflammation and immune-related uses
04/03/2008WO2008038955A1 Benzophenone derivatives useful for inhibiting formation of microtubule
04/03/2008WO2008038132A1 Crystalline diamine salts of rosuvastatin
04/03/2008WO2008015563A3 Salts of rosuvastatin and processes for their preparation
04/03/2008WO2007125547A3 Novel process for statins and its pharmaceutically acceptable salts thereof
04/03/2008US20080081811 5-[2-(cyclohexyloxy)-6-methyl-4-pyrimidinyl]-2-[5-(4-methyl-1-piperazinyl)methyl-2-pyrazinyl]amino-1,3-thiazole; anticarcinogenic agent; G1 phase in cell cycle; great selectivity
04/02/2008EP1905765A1 6-arylamino-5-cyano-4-pyrimidinone as PDE9A-inhibitors
04/02/2008EP1905441A2 Non-sedating barbiturate compounds as neuroprotective agents
04/02/2008EP1904459A1 New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide
04/02/2008EP1904458A1 Method for the production of quinazolinone derivatives
04/02/2008EP1904457A2 Compositions and methods for inhibition of the jak pathway
04/02/2008EP1904456A1 Processes for the manufacture of rosuvastatin and intermediates
04/02/2008EP1575949B1 Fungicides
04/02/2008EP1201648B1 Carbamate derivatives and agricultural/horticultural bactericides
04/02/2008CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
04/02/2008CN101155788A Crystal of 4(3h)-quinazolinone derivative
04/02/2008CN101155787A (3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines
04/02/2008CN101155786A N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
04/02/2008CN101155785A Novel adenosine a3 receptor modulators
04/02/2008CN100378101C 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives
04/02/2008CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives
04/02/2008CN100378082C Pyrimidine compounds and pests controlling composition containing the same
04/02/2008CN100378081C Process for the manufacture of organic compounds
04/02/2008CN100378072C Heterocyclic methyl sulfone derivative
04/01/2008US7351829 Compounds on the basis of 2- and 4-chromenylidene-merocyanines respectively, and their use
04/01/2008US7351826 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds
04/01/2008US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
04/01/2008US7351733 Tetrahydrocarbazole derivatives and their pharmaceutical use
04/01/2008US7351700 4-(2-Hexylsulfanyl-6-methyl-pyrimidin-4-ylmethyl)-morpholine; antidepressant, anxiolytic agent, cognition activator; epilepsy, schizophrenia, spasticity and skeletal muscle rigidity, spinal cord injury, multiple sclerosis, amyotrophic lateral sclerosis, neuropathic pain
03/2008
03/27/2008WO2008036843A2 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors
03/27/2008WO2008036286A1 Crystalline rosuvastatin calcium
03/27/2008WO2008035359A2 Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives
03/27/2008WO2008002671A3 Metalloprotease inhibitors
03/27/2008WO2007056163A3 Aminopyrimidines useful as kinase inhibitors
03/27/2008WO2007020411A8 Amide derivatives
03/27/2008US20080076914 Method of Deprotection
03/27/2008US20080076785 Phytopathogenic
03/27/2008US20080076784 Bicyclic, Nitrogen-Containing Heterocycles and Aromatase Inhibitors
03/27/2008US20080076783 Cycloalkyl Keto Piperidine Tachykinin Receptor Antagonists
03/27/2008US20080076667 Substituted fluoroalkoxyphenylsulfonylureas
03/27/2008US20080076188 Luminescent compounds
03/27/2008DE112005003498T5 Herstellungsverfahren für Chinazolinderivate und Anwendung zur Herstellung zur Behandlung von Tumorerkrankungen A method for manufacturing and application for the production of quinazoline derivatives for the treatment of tumor diseases
03/27/2008DE102006021874B4 4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, process for their preparation and their use as medicaments
03/27/2008CA2664411A1 Platelet adp receptor inhibitors
03/26/2008EP1903030A1 Method for catalytic manufacture of aromatic or heteroaromatic nitriles
03/26/2008EP1902037A1 2,4-diamino-pyrimidines used as aurora inhibitors
03/26/2008EP1902036A2 Process for the preparation of rosuvastatin
03/26/2008EP1509218A4 Peptide deformylase inhibitors
03/26/2008EP1455790B1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
03/26/2008CN101151261A Pyrimidine compounds having tie2 (TEK) inhibitory activity
03/26/2008CN101151258A Pyrimidine derivatives for treatment of hyperproliferative disorders
03/26/2008CN101151255A 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
03/26/2008CN101151254A Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
03/26/2008CN101151253A Substituted n-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators
03/26/2008CN101151252A Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors
03/26/2008CN101148439A Preparing method for gefitinib
03/26/2008CN100376580C Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
03/26/2008CN100376571C 6-substituted pyrido-pyrimidines
03/26/2008CN100376246C Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
03/25/2008US7348335 Compositions useful as inhibitors of JAK and other protein kinases
03/25/2008US7348334 Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them
03/25/2008US7348333 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies
03/25/2008US7348332 (3,4-dihydro-quinazolin-2-yl)-(R)-indan-1-yl-amine; serotonin (5-HT5A) receptor antagonist/agonist; anxiolitic, antidepressant, sleep disorders and schizophrenia; amination thioquinazolin with 1-aminoindane
03/25/2008US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy
03/20/2008WO2008033834A1 Pyrimidines derivatives and their use as kinase inhibitors
03/20/2008WO2008031888A2 Condensed pyrimidinones active on glutamatergic receptors
03/20/2008WO2008031556A2 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions
03/20/2008WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS
03/20/2008WO2007144769A3 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics